Drug Trial Radar · NCT07390123
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Last checked: Nov 19, 2026Latest source record: May 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
370
Planned (sponsor's estimate)
Start
Apr 7, 2026
Primary completion
Dec 2027
Study completion Jul 2028
Sponsor
- Lead sponsor
- Haisco Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 5, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the efficacy and safety of HSK39297 tablets in patients with primary IgAN
Conditions
- IgA Nephropathy (IgAN)
Interventions
HSK39297Drug
HSK39297 200mg, once a day; treatment period; 48-weeks fixed dose.
PlaceboDrug
Placebo, once a day; treatment period; 48-weeks fixed dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Ratio to baseline in Urine Protein to Creatinine Ratio (sampled from 24h urine collection) at 36 weeksTime frame: From week 1 to week 36
- Annualized total estimated Glomerular Filtration Rate slope over 48 weeksTime frame: From week 1 to week 48
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Huangshan City People's Hospital
Huangshan City, Anhui, China · Recruiting
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, China · Recruiting
Peking University First Hospital
Beijing, Beijing Municipality, China · Recruiting
Zhanjiang Central Hospital
Zhanjiang, Guangdong, China · Recruiting
Xiangya Hospital of Central South University
Changsha, Hunan, China · Recruiting
The Second Hospital of Jilin University
Changchun, Jilin, China · Recruiting
Linyi City People Hospital
Linyi, Shandong, China · Recruiting
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China · Recruiting
Xijing Hospital
Xi’an, Shanxi, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.